Skip to search formSkip to main contentSkip to account menu

carcinoma poorly differentiated

Known as: poorly differentiated carcinoma 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Primary malignant neoplasm

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Poorly Differentiated and Undifferentiated Thyroid Carcinomas.
Thyroid cancer is the most common endocrine malignancy and its incidence goes on increasing worldwide. The majority of thyroid… 
Review
2012
Review
2012
Classification of thyroid follicular cell tumors: with special reference to borderline lesions.
We propose a new classification of thyroid follicular cell tumors which is correlated with patient's prognosis. It is unique as… 
2011
2011
Genetic profile of adenoid cystic carcinomas (ACC) with high-grade transformation versus solid type
BackgroundACC can occasionally undergo dedifferentiation also referred to as high-grade transformation (ACC-HGT). However, ACC… 
Highly Cited
2002
Highly Cited
2002
Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992.
Highly Cited
1997
Highly Cited
1997
Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma?
PURPOSE The objectives of this study were to assess clinical outcomes and prognostic factors in unselected, consecutive patients… 
Highly Cited
1997
Highly Cited
1997
Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide.
PURPOSE To evaluate the efficacy and toxicity of a novel chemotherapy combination that includes paclitaxel, carboplatin, and… 
Highly Cited
1996
Highly Cited
1996
p53 gene mutation in thyroid carcinoma.
Highly Cited
1994
Highly Cited
1994
A Novel Panel of Antibodies that Segregates Immunocytochemically Poorly Differentiated Carcinoma from Undifferentiated Carcinoma of the Thyroid Gland
The expression of bcl-2 and p53 was investigated by immunocytochemistry in combination with that of conventional structural and… 
Highly Cited
1992
Highly Cited
1992
Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience.
PURPOSE We previously reported excellent responses to cisplatin-based chemotherapy in a minority of patients with poorly… 
Review
1987
Review
1987
Poorly differentiated carcinoma of unknown primary site: correlation of light microscopic findings with response to cisplatin-based combination chemotherapy.
We have previously reported complete responses and long-term survival in patients with metastatic poorly differentiated carcinoma… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)